Vishal S. Narang

411 total citations
10 papers, 345 citations indexed

About

Vishal S. Narang is a scholar working on Oncology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Vishal S. Narang has authored 10 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Infectious Diseases and 2 papers in Molecular Biology. Recurrent topics in Vishal S. Narang's work include HIV/AIDS drug development and treatment (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Amino Acid Enzymes and Metabolism (2 papers). Vishal S. Narang is often cited by papers focused on HIV/AIDS drug development and treatment (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Amino Acid Enzymes and Metabolism (2 papers). Vishal S. Narang collaborates with scholars based in United States, India and Canada. Vishal S. Narang's co-authors include Donna J. Buckley, Christopher M. Waters, Narendra Kumar, Arthur R. Buckley, Peter W. Gout, Giovanni M. Pauletti, Charles H. Fraga, Jun Shen, Clinton F. Stewart and Stacy L. Throm and has published in prestigious journals such as Journal of Biological Chemistry, American Journal of Physiology-Cell Physiology and Pharmacological Research.

In The Last Decade

Vishal S. Narang

10 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vishal S. Narang United States	8	182	104	69	47	42	10	345
Phillip D. Gray United States	10	90 0.5×	110 1.1×	94 1.4×	43 0.9×	15 0.4×	13	353
S. Harigae Japan	10	178 1.0×	183 1.8×	57 0.8×	69 1.5×	28 0.7×	11	370
An–Qiang Sun United States	14	501 2.8×	253 2.4×	112 1.6×	50 1.1×	48 1.1×	21	777
Lindsay C. Czuba United States	10	112 0.6×	200 1.9×	36 0.5×	40 0.9×	23 0.5×	21	374
Yi-Ping Rao United States	11	337 1.9×	237 2.3×	37 0.5×	59 1.3×	12 0.3×	12	562
Yoshihiko Shibayama Japan	11	139 0.8×	239 2.3×	33 0.5×	37 0.8×	19 0.5×	26	445
Takayuki Tanabe Japan	10	55 0.3×	157 1.5×	33 0.5×	35 0.7×	36 0.9×	44	445
Francisco Chung United States	10	124 0.7×	123 1.2×	58 0.8×	26 0.6×	7 0.2×	13	345
Kevin M. Huang United States	12	151 0.8×	103 1.0×	30 0.4×	19 0.4×	21 0.5×	28	343

Countries citing papers authored by Vishal S. Narang

Since Specialization

Citations

This map shows the geographic impact of Vishal S. Narang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vishal S. Narang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vishal S. Narang more than expected).

Fields of papers citing papers by Vishal S. Narang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vishal S. Narang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vishal S. Narang. The network helps show where Vishal S. Narang may publish in the future.

Co-authorship network of co-authors of Vishal S. Narang

This figure shows the co-authorship network connecting the top 25 collaborators of Vishal S. Narang. A scholar is included among the top collaborators of Vishal S. Narang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vishal S. Narang. Vishal S. Narang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Narang, Vishal S., et al.. (2011). Pharmacokinetic Profiling and Bioequivalence Assessment of Two Marketed Brands of Nevirapine Tablets in Healthy Indian Volunteers. Arzneimittelforschung. 55(10). 598–603. 1 indexed citations

Narang, Vishal S., Charles H. Fraga, Narendra Kumar, et al.. (2008). Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier. American Journal of Physiology-Cell Physiology. 295(2). C440–C450. 115 indexed citations

Narang, Vishal S., Giovanni M. Pauletti, Peter W. Gout, Donna J. Buckley, & Arthur R. Buckley. (2007). Sulfasalazine-Induced Reduction of Glutathione Levels in Breast Cancer Cells: Enhancement of Growth-Inhibitory Activity of Doxorubicin. Chemotherapy. 53(3). 210–217. 65 indexed citations

Kumar, Narendra, Jayshree Mishra, Vishal S. Narang, & Christopher M. Waters. (2007). Janus Kinase 3 Regulates Interleukin 2-induced Mucosal Wound Repair through Tyrosine Phosphorylation of Villin. Journal of Biological Chemistry. 282(42). 30341–30345. 37 indexed citations

Kirby, Brian, et al.. (2006). Simultaneous Measurement of In Vivo P‐glycoprotein and Cytochrome P450 3A Activities. The Journal of Clinical Pharmacology. 46(11). 1313–1319. 38 indexed citations

Narang, Vishal S., et al.. (2005). A Combined‐Formulation Tablet of Lamivudine/Nevirapine/Stavudine: Bioequivalence Compared With Concurrent Administration of Lamivudine, Nevirapine, and Stavudine in Healthy Indian Subjects. The Journal of Clinical Pharmacology. 45(3). 265–274. 13 indexed citations

Narang, Vishal S., et al.. (2005). Pharmacokinetic Profiling and Bioequivalence Evaluation of 2 Lamivudine Tablet Formulations After Single Oral Administration in Healthy Human Indian Volunteers. JAIDS Journal of Acquired Immune Deficiency Syndromes. 38(5). 566–569. 8 indexed citations

Narang, Vishal S., et al.. (2004). Bioequivalence evaluation of two marketed brands of stavudine 40mg capsules in healthy human South African volunteers. Pharmacological Research. 50(5). 511–516. 6 indexed citations

Narang, Vishal S., Giovanni M. Pauletti, Peter W. Gout, Donna J. Buckley, & Arthur R. Buckley. (2004). Suppression of cystine uptake by sulfasalazine inhibits proliferation of human mammary carcinoma cells.. PubMed. 23(6C). 4571–9. 41 indexed citations

10.

Krumenacker, Joshua S., Vishal S. Narang, Donna J. Buckley, & Arthur R. Buckley. (2001). Prolactin signaling to pim-1 expression: a role for phosphatidylinositol 3-kinase. Journal of Neuroimmunology. 113(2). 249–259. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact